Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |